EBMT 2019 | Regulatory and commercialization challenges with CAR T-cell therapy

Bruce Levine

Bruce Levine, PhD, from the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, discusses the challenges regarding regulatory and commercialization of CAR T-cell therapy. Dr Levine was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video